What is the main business of Econorm-Biotech?

The main business activity of Econorm-Biotech focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 12, 2016.

Where is the headquarters located?

The headquarters is located at: Łódź.

Who is on the management board?

The management board consists of: Henryk Tadeusz Panusz (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 30,000 (approx. $8,104).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

Yes, in 2023 the company achieved a net profit of USD 0.

Econorm-Biotechsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-07-12

Share capital

30,000.00 PLN

Registered address

Łódź, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 368 days for 2020).

2024not filed
202328/06/2024
202228/06/2024
202123/06/2023
202018/10/2022
201915/10/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Other research and experimental development on natural sciences and engineering (72.19.Z)Primary
Management consultancy activities (70.2)
Research and experimental development in natural sciences and engineering (72.1)

Authorized Representatives

Henryk Tadeusz Panusz – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Henryk Tadeusz Panuszage 97	60	$8,103.73	100%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Faurecia R&D CenterS.A.	$33,566,047.21	faureciardcentersa.pl
WP Radwansp. z o.o.	$2,306,366.78	woodpartners.eu
Prodel R&Dsp. z o.o.	$941,906.54	prodel.com.pl
CTI Clinical Trial and Consulting Services Polandsp. z o.o.	$527,145.56	ctifacts.com
Alergo-Med Specjalistyczna Przychodnia Lekarskasp. z o.o.	$271,470.30	alergomed.tarnow.pl
Edurocosp. z o.o.	$126,644.58	eduroco.pl
ConnectomeP.S.A.	$107,988.50	connectome.name
.Protsp. z o.o.	$34,756.89	dotprot.com
TriomegaS.A.	$17,836.84	triomega.pl
Cannabis Housesp. z o.o.	$12,938.24	cannabishouse.eu

Change history

Date	Event
2026-10-01	Address change (Al. Tadeusza Kościuszki 1, 90-418, Łódź → Łódź)
2025-05-27	Business resumed
2020-12-01	Business suspended
2016-07-12	Entered in the register

FAQ

Last updated: 2026-10-01